Table 3.
Price in U.S. dollars of anti-malarial medicines and malaria rapid diagnostic tests by drug-outlet type in Siaya County, Kenya—2013
Overall median | Overall mean (range) | Registered pharmacy mean (range) | Informal shop mean (range) | General shop mean (range) | Homestead mean (range) | Other mean (range) | |
---|---|---|---|---|---|---|---|
Price in U.S. dollars ($)a | |||||||
Artemisinin-based combination therapy | |||||||
Artemether-lumefantrine | 0.94 | 1.01 (0.35–4.71) |
1.28 (0.35–4.71) |
1.00 (0.35–2.94) |
0.92 (0.35–1.76) |
1.09 (0.71–1.76) |
1.06 (0.94–1.41) |
Dihydroartemisinin-piperaquine | 4.14 | 4.39 (0.71–7.06) |
4.38 (0.71–7.06) |
4.45 (3.53–5.29) |
4.12 (3.53–4.71) |
– | – |
Artesunate-amodiaquine | 0.71 | 0.71 (0.59–1.18) |
0.63 (0.59–0.71) |
0.73 (0.59–1.18) |
0.71 (NAb) |
0.82 (NA) |
– |
Artemisinin-piperaquine | 5.47 | 5.53 (5.29–5.88) |
5.61 (5.29–5.88) |
5.29 (NA) |
– | – | – |
Quinine formulations | |||||||
Tablets | 2.31 | 2.24 (0.12–4.71) |
2.93 (1.09–4.71) |
1.86 (0.12–3.53) |
2.82 (NA) |
1.62 (0.59–2.65) |
2.35 (0.88–3.81) |
Parenteral (600 mg/2 ml vial) | 0.35 | 0.48 (0.24–1.06) |
0.50 (0.24–1.06) |
0.51 (0.29–1.06) |
0.41 (0.35–0.47) |
0.41 (NA) |
0.33 (0.29–0.35) |
Paediatric suspensionc (50 mg/5 ml) | 0.82 | 0.94 (0.53–2.35) |
0.75 (0.53–0.94) |
1.00 (0.53–2.35) |
0.82 (NA) |
– | – |
Sulfadoxine-pyrimethamine | 0.47 | 0.62 (0.24–2.35) |
0.76 (0.29–1.76) |
0.68 (0.35–2.35) |
0.39 (0.24–0.82) |
0.50 (0.35–0.82) |
0.91 (0.35–1.76) |
Amodiaquine monotherapy | 0.35 | 0.42 (0.24–1.06) |
– | 0.33 (0.29–0.35) |
0.45 (0.24–1.06) |
0.35 (NA) |
– |
Artemether, parenteral (80 mg/ml vial) | 1.18 | 1.53 (0.47–4.12) |
1.75 (0.94–4.12) |
0.82 (0.47–1.18) |
– | – | 1.18 (NA) |
Malaria rapid diagnostic tests | 0.59 | 0.92 (0.24–2.35) |
1.02 (0.35–2.35) |
0.87 (0.24–2.35) |
– | 0.71 (0.35–1.18) |
– |
Price per standard adult-equivalent treatment dose for all medicines except parenteral and paediatric suspension formulations
aAll prices in U.S. dollars (USD) converted from Kenya Shillings (KES) based on exchange rate in October 2013 (1 USD = 85 KES)
b NA not applicable. Only one price for the medicine formulation; no range reported
cPrice analysis for most common formulation only, which represented 87.5 % (21/24) of total